Takenaka Partners Advises The Mentholatum Company on its Acquisition of Hydrox Laboratories

Takenaka Partners Advises The Mentholatum Company on its Acquisition of Hydrox Laboratories

Takenaka Partners LLC (Los Angeles, CA) acted as the financial advisor to The Mentholatum Company, Inc. (“Mentholatum”) on its acquisition of Hydrox Laboratories (“Hydrox”). Through this transaction, Mentholatum looks to provide opportunities that will grow its capabilities in sales, manufacturing, and research and development.

Based in Orchard Park, N.Y., Mentholatum is a world leader in the manufacturing and marketing of pharmaceuticals, cosmetics, skincare, and health care products. It is parent to such brands as Rohto eyedrops, Oxy Acne Care, Mentholatum Ointment and Soft Lips, as well as Private Label products.

Hydrox Laboratories was established in 1913 and is one of the oldest continuously running manufacturing companies in the United States. The company manufactures health and beauty products such as baby care, personal care, hand hygiene, infection prevention, first aid antiseptics, disinfectants, and surgical instrument care.

With the acquisition of Hydrox, Mentholatum has expanded its offerings to include disinfectants, cleaners, and antiseptics, resulting in increased B2B sales to hospitals and other healthcare companies.